Bioconversion of AS1387392 : bioconversion studies involving Amycolatopsis azurea JCM 3275
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-11-25
著者
-
YAMADA Toshiko
Pharmacology Research Laboratories, Astellas Pharma Inc.
-
Fujie Akihiko
Fermentation Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Mori H
Medicinal Biology Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
MORI Hiroaki
Pharmacology Research Laboratory, Astellas Pharmaceutical Inc.
-
Sakamoto Kazutoshi
Fermentation Research Laboratories Astellas Pharma Inc.
-
Sakamoto Kazutoshi
National Research Institute Of Brewing
-
Fujii T
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Takase Shigehiro
Fermentation Research Laboratories Drug Discovery Research Astellas Pharma Inc.
-
Hashimoto Michizane
Fermentation Research Laboratories Drug Discovery Research Astellas Pharma Inc.
-
Hashimoto Michizane
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Hino Motohiro
Fermentation Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Ohsumi Keisuke
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Takase S
Fermentation Research Laboratories Drug Discovery Research Astellas Pharma Inc.
-
Fujie Akihiko
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Hino Motohiro
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Hino Motohiro
Fermentation Research Laboratories Drug Discovery Research Astellas Pharma Inc.
-
Muramatsu Hedeyuki
Fermentation Research Laboratories Drug Discovery Research Astellas Pharma Inc.
-
Hino Motohiro
Fermentation And Biotechnology Laboratories Astellas Pharma Inc.
-
Yamada Toshiko
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Fujii Takashi
Exploratory Research Laboratories Fujisawa Pharmaceutical Co
-
Hashimoto Michizane
Fermentation And Biotechnology Laboratories
-
Muramatsu Hideyuki
Fermentation Research Div. Astellas Research Technologies Co. Ltd.
-
Fujie Akihiko
Research Planning And Administration Astellas Pharma
-
Ohsumi Keisuke
Molecular Medicine Research Laboratories Astellas Pharma Inc.
-
SASAMURA Satoshi
Pharmacology Research Laboratories, Astellas Pharma Inc.
-
TAKASE Shigehiro
Analysis & Pharmacokinetics Research Laboratories, Astellas Pharma Inc.
-
Fujii Takashi
Exploratory Research Laboratories Astellas Pharma Inc.
-
Mori Hiroaki
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Fujie Akihiko
Research Planning & Administration
-
Fujie Akihiko
Research Management, Astellas Pharma Inc.
関連論文
- Improvement of FR901379 production by mutant selection and medium optimization(BIOCHEMICAL ENGINEERING)
- Novel Method for Selecting Immunosuppressive Histone Deacetylase (HDAC) Inhibitors with Minimal Thrombocytopenia(Molecular and Cell Biology)
- The Novel Gluconeogenesis Inhibitors FR225659 and Related Compounds that Originate from Helicomyces sp. No. 19353 : II. Biological Profiles
- Effect of a New Immunosuppressant Histon Deacetylase (HDAC) Inhibitor FR276457 in a Rat Cardiac Transplant Model(Pharmacology)
- Naphthalecin, a Novel Antibiotic Produced by the Anaerobic Bacterium, Sporotalea colonica sp. nov.
- FR901512, a Novel HMG-CoA Reductase Inhibitor Produced by an Agonomycetous Fungus No. 14919 : II. Biological Profiles
- FR901512, a Novel HMG-CoA Reductase Inhibitor Produced by an Agonomycetous Fungus No. 14919 : I. Taxonomy of the Producing Organism, Fermentation, Islation and Physico-chemical Properties
- FR171456, a Novel Cholesterol Synthesis Inhibitor Produced by Sporormiella minima No. 15604 : II. Biological Activities
- FR171456, a Novel Cholesterol Synthesis Inhibitor Produced by Sporormiella minima No. 15604 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties
- The Novel Gluconeogenesis Inhibitors FR225659 and Related Compounds that Originate from Helicomyces sp. No.19353 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
- FR235222, a Fungal Metabolite, is a Novel Immunosuppressant that Inhibits Mammalian Histone Deacetylase (HDAC) II. Biological Activities in Animal Models
- FR252921, a Novel Immunosuppressive Agent Isolated from Pseudomonas fluorescens No.408813 III. In Vivo Activities
- FR235222, a Fungal Metabolite, is a Novel Immunosuppressant that Inhibits Mammalian Histone Deacetylase (HDAC) I. Taxonomy, Fermentation, Isolation and Biological Activities
- FR252921, a Novel Immunosuppressive Agent Isolated from Pseudomonas fluorescens No.408813 II. In Vitro Property and Mode of Action
- FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No.11243 : II. In Vitro and In Vivo Activities
- FR227673 and FR190293, Novel Antifungal Lipopeptides from Chalara sp. No. 22210 and Tolypocladium parasiticum No. 16616
- FR207944, an Antifungal Antibiotic from Chaetomium sp. No. 217 : I. Taxonomy, Fermentation, and Biological Properties
- FR227244, a Novel Antifungal Antibiotic from Myrothecium cinctum No. 002 : II. Biological Properties and Model of Action
- FR235222, a Fungal Metabolite, is a Novel Immunosuppressant that Inhibits Mammalian Histone Deacetylase III. Structure Determination
- A New Antimitotic Substance, FR182877 : II. The Mechanism of Action
- New Antitumor Substances, FR901463, FR901464 and FR901465 III. Structures of FR901463, FR901464 and FR901465
- New Antitumor Substances, FR901464 and FR901465 I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
- Site-specific Structural Transformation of the Novel Antifungal Cyclic Depsipeptide FR901469 : Synthesis and Biological Activity of FR203904
- Cloning and Analysis of the AWA1 Gene of a Nonfoaming Mutant of a Sake Yeast
- FR220897 and FR220899, Novel Antifungal Lipopeptides from Coleophoma empetri No. 14573
- FR209602 and Related Compounds, Novel Antifungal Lipopeptides from Coleophoma crateriformis No. 738 : II. In Vitro and In Vivo Antifungal Activity
- FR227244, a Novel Antifungal Antibiotic from Myrothecium cinctum No. 002 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
- FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No. 11243 : III. Structure Determination
- FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No.11243 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Properties
- FR209602 and Related Compounds, Novel Antifungal Lipopeptides from Coleophoma crateriformis No. 738 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
- FR198248, a New Anti-influenza Agent isolated from Aspergillus terreus No.13830 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
- FR901483, a Novel Immunosuppressant Isolated from Cladobotryum sp. No. 11231 Taxonomy of the Producing Organism, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
- The Novel Gluconeogenesis Inhibitor FR225654 that Originates from Phoma sp. No. 00144 : III. Structure Determination
- FR207944, an Antifungal Antibiotic from Chaetomium sp. No. 217 : II. Isolation and Structure Elucidation
- A New Antimitotic Substance, FR182877 : III. Structure Determination
- Oxidative Activities of Heterologously Expressed CYP107B1 and CYP105D1 in Whole-Cell Biotransformation Using Streptomyces lividans TK24(ENZYMOLOGY, PROTEIN ENGINEERING, AND ENZYME TECHNOLOGY)
- The Novel Gluconeogenesis Inhibitor FR225654 that Originates from Phoma sp. No. 00144 : II. Biological Activities
- The Novel Gluconeogenesis Inhibitor FR225654 that Originates from Phoma sp. No. 00144 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
- FR182876, a New Microtubule Modulator with High Water-solubility, from a Streptomyces
- The Novel Gluconeogenesis Inhibitors FR225659 and FR225656 from Helicomyces sp. No. 19353 : III. Structure Determination
- FR252921, a Novel Immunosuppressive Agent Isolated from Pseudomonas fluorescens No.408813 I. Taxonomy, Ferimentation, Isolation, Physico-chemical Properties and Biological Activities of FR252921, FR252922 and FR256523
- New Anti-influenza Agents, FR198248 and Its Derivatives : II. Characterization of FR198248, Its Related Compounds and Some Derivatives
- FR191512 , a Novel Anti-influenza Agent Isolated from a Fungus Strain No.17415 : II. Biological Properties
- FR191512 , a Novel Anti-influenza Agent Isolated from a Fungus Strain No.17415 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Structure Elucidation
- FR225659-binding Proteins : Identification as Serine/Threonine Protein Phosphatase PP1 and PP2A Using High-performance Affinity Beads
- A Comparative Study of Malaysian and Japanese Actinomycetes Using a Simple Identification Method Based on Partial 16S rDNA Sequence
- A New Antimitotic Substance, FR182877 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
- WF14865A and B, New Cathepsins B and L Inhibitors Produced by Aphanoascus fulvescens I. Taxonomy, Production, Purification and Biological Properties
- WF14861, a New Cathepsins B and L Inhibitor Produced by Colletotrichum sp. I. Taxonomy, Production Purification and Structure Elucidation
- WS75624 A and B, New Endothelin Converting Enzyme Inhibitors Isolated from Saccharothrix sp.No.75624 I.Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
- WF14861, a New Cathepsins B and L Inhibitor Produced by Collectotrichum sp. II. Biological Properties
- WA8242A_1, A_2 and B, Novel Secretary Phospholipase A_2 Inhibitors Produced by streptomyces violaceusinger III. Structure Elucidation and Total Synthesis of WA8242B
- Cloning and Heterologous Expression of the Antibiotic Peptide (ABP) Genes from Rhizopus oligosporus NBRC 8631
- The Promoter Activity of Isovaleryl-CoA Dehydrogenase-Encoding Gene (ivdA) from Aspergillus oryzae Is Strictly Repressed by Glutamic Acid
- Aflatoxin non-productivity of Aspergillus oryzae caused by loss of function in the aflJ gene product(GENETICS, MOLECULAR BIOLOGY, AND GENE ENGINEERING)
- Gene Silencing by RNA Interference in the Koji Mold Aspergillus oryzae
- A New Aromatase Inhibitor, FR901537 I.Taxonomy, Fermentation, Isolation, Physicochemical Characteristics
- WS75624 A and B, New Endothelin Converting Enzyme Inhibitors Isolated from Saccharothrix sp.No.75624 II.Structure Elucidation of WS75624 A and B
- Sulfated glycofuranans as inhibitors of melanoma lung metastasis
- Development of a simple-identification method for actinomycetes based on partial 16S rDNA sequences as exemplified by a comparative study of Malaysian and Japanese actinomycetes
- Strain selection and scale-up fermentation for FR901379 acylase production by Streptomyces sp. no. 6907(METHOD)
- Lack of endoplasmic reticulum 1,2-α-mannosidase activity that trims N-glycan Man_9GlcNAc_2 to Man_8GlcNAc_2 isomer B in a manE gene disruptant of Aspergillus oryzae(GENETICS, MOLECULAR BIOLOGY, AND GENE ENGINEERING)
- Cloning and expression of the FR901379 acylase gene from Streptomyces sd. no. 6907
- Anti-herpes virus activity of polyether antibiotic CP-44161 in vivo
- Discovery of anti-varicella zoster virus activity of polyether antibiotic CP-44161
- Screening and evaluation of new inhibitors of hepatic glucose production
- Phylogenetic diversity of acidophilic actinomycetes from Malaysia
- Screening and characterization of microorganisms with FR901379 acylase activity
- Lack of endoplasmic reticulum 1,2-αmannosidase activity that trims N-glycan Man_9GlcNAc_2 to Man_8GlcNAc_2 isomer B in a manE gene disruptant of Aspergillus oryzae
- AS1387392, a novel immunosuppressive cyclic tetrapeptide compound with inhibitory activity against mammalian histone deacetylase
- Cloning and heterologous expression of P450Um-1, a novel bacterial P450 gene, for hydroxylation of immunosuppressive agent AS1387392
- Bioconversion of AS1387392 : bioconversion studies involving Amycolatopsis azurea JCM 3275
- Bioconversion of AS1387392 : screening and characterization of actinomycetes that convert AS1387392 to AS1429716
- Enhanced oxidative activities of cytochrome P450Rhf from Rhodococcus sp. expressed using the hyper-inducible expression system(GENETICS, MOLECULAR BIOLOGY, AND GENE ENGINEERING)
- Streptomyces tsukubensis sp. nov., a producer of the immunosuppressant tacrolimus